Q0167
Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Effective Date: 1998-04-01
- Medicare Coverage Status: Special coverage instructions apply
- BETOS Classification: Chemotherapy
Medicare has not assigned a fee schedule for this code
Q0166
Q0169 